ijms-logo

Journal Browser

Journal Browser

Pain: From Bench to Bedside

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 20 September 2026 | Viewed by 2602

Special Issue Editors


E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Interests: anesthesia; pain management

Special Issue Information

Dear Colleagues,

This Special Issue, “Pain: From Bench to Bedsides”, highlights advances in the mechanistic understanding of pain and the translation into novel therapeutic treatments. Despite significant unmet clinical needs, recent scientific discoveries have identified new targets across ion channels, neuroimmune pathways, and receptor systems, enabling the development of non-opioid analgesics and biologics. This issue will feature research on emerging therapies targeting pathways such as TRP channels, NaV channels, CGRP, glial modulation, and ascending and descending modulating pain pathways, among others. Contributions leveraging transcriptomics, proteomics, neuromodulation, and imaging to elucidate pain pathophysiology are encouraged. Additionally, the integration of machine learning into drug discovery is accelerating the identification of candidate molecules and optimizing pharmacological profiles. Submissions exploring machine learning-driven target prediction, compound screening, and structure-activity modeling are particularly welcome. By bridging molecular insights with therapeutic development, this issue aims to provide a comprehensive view of current strategies advancing the treatment of acute and chronic pain conditions across clinical and translational domains.

This Special Issue is supervised by Dr. Christopher Robinson and Dr. Robert J. Yong, assisted by Guest Editor Assistant Dr. Woojin Lee (, Department of Anesthesiology, Brown University Health, The Warren Alpert Medical School, Brown University, Providence, RI 02912 , USA).

Dr. Christopher Robinson
Dr. Robert J. Yong
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • CGRP pathway
  • chronic pain
  • drug discovery
  • ion channels
  • machine learning
  • molecular targets
  • neuroimmune signaling
  • non-opioid analgesics
  • translational pain research
 
 
 

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

12 pages, 359 KB  
Perspective
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management
by Claire Yuan, Ariana Demers, Victor Silva-Ortiz, Jamal J. Hasoon, Woojin Lee, Karan Dave, Kasra Amirdelfan, Harold W. Burke, Paul J. Christo and Christopher L. Robinson
Int. J. Mol. Sci. 2026, 27(6), 2876; https://doi.org/10.3390/ijms27062876 - 22 Mar 2026
Viewed by 2097
Abstract
Body Protective Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from gastric proteins that has demonstrated notable reparative and anti-inflammatory properties across diverse preclinical models. Experimental evidence reveals that BPC-157 supports angiogenesis, collagen synthesis, fibroblast activity, and modulation of nitric oxide pathways, contributing to [...] Read more.
Body Protective Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from gastric proteins that has demonstrated notable reparative and anti-inflammatory properties across diverse preclinical models. Experimental evidence reveals that BPC-157 supports angiogenesis, collagen synthesis, fibroblast activity, and modulation of nitric oxide pathways, contributing to enhanced healing of muscle, tendon, ligament, bone, and gastrointestinal tissue. Studies also report reduced inflammatory cytokine activity, improved microvascular integrity, and beneficial effects on pain modulation through peripheral and dopaminergic mechanisms. Although animal data indicate favorable safety and pharmacokinetics, human research remains limited to small pilot studies investigating musculoskeletal pain, interstitial cystitis, and intravenous administration, all suggesting potential therapeutic value without reported major adverse effects. However, inconsistent preparation standards, limited clinical validation, and regulatory restrictions underscore the need for rigorous controlled trials. BPC-157 remains a promising candidate for regenerative medicine, yet comprehensive evaluation is required before clinical translation can be recommended. Full article
(This article belongs to the Special Issue Pain: From Bench to Bedside)
Back to TopTop